secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001493152-24-030963
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health Q2 revenue $2.0M (+101% YoY); net loss widens to $1.4M
------------------------------------------------------------------

- Revenue $2.0M vs $1.0M in Q2 2023; Population Health grew 276% YoY, Healthcare Workforce 66%.
- Gross margin improved to 17.8% from 13.1% on mix shift toward higher-margin population health.
- Net loss of $1.4M compared to $802.8K loss in Q2 2023; Adjusted EBITDA -$1.3M vs -$771K.
- Cash $1.6M and no long-term debt; 25% reduction in executive pay implemented starting Q3 2024.
- Subcontractor on $43B DHA workforce contract vehicle; $5.8M Indiana health education contract.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224030963/0001493152-24-030963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224030963/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer